Millennium Management
TRAW icon

Millennium Management’s Traws Pharma TRAW Stock Holding History

Millennium Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,071
Closed -$23.2K – 6423
2025
Q1 		$23.2K Buy
10,071
+59
+0.6% +$307 ﹤0.01% 5615
2024
Q4 		$88.9K Buy
+10,012
New +$55.7K ﹤0.01% 5491
2024
Q1 		– Sell
-620
Closed -$11.5K – 6741
2023
Q4 		$11.5K Buy
620
+154
+33% +$2.62K ﹤0.01% 5718
2023
Q3 		$8.41K Sell
466
-43
-8% -$981 ﹤0.01% 5788
2023
Q2 		$15K Buy
+509
New +$13.7K ﹤0.01% 5683
2023
Q1 		– Sell
-1,218
Closed -$20K – 6959
2022
Q4 		$20K Sell
1,218
-1,151
-49% -$21.7K ﹤0.01% 6048
2022
Q3 		$52K Sell
2,369
-87
-4% -$2.63K ﹤0.01% 6177
2022
Q2 		$81K Buy
2,456
+1,491
+155% +$50.3K ﹤0.01% 6016
2022
Q1 		$44K Buy
965
+423
+78% +$19.6K ﹤0.01% 6435
2021
Q4 		$35K Buy
+542
New +$43.6K ﹤0.01% 6541
2021
Q2 		– Sell
-7,534
Closed -$2.82M – 7211
2021
Q1 		$2.82M Buy
+7,534
New +$2.84M ﹤0.01% 3196
2018
Q2 		– Sell
-3
Closed -$12K – 4244
2018
Q1 		$12K Buy
+3
New +$21.4K ﹤0.01% 3575
2015
Q1 		– Sell
-1
Closed -$117K – 4198
2014
Q4 		$117K Buy
+1
New +$245K ﹤0.01% 3749
2014
Q3 		– Hold
0
– – – 3605

Other funds holding TRAW

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management's TRAW Position: Q2 2025 in Review

Millennium Management sold out of Traws Pharma (TRAW) in Q2 2025, closing a stake of 10,071 shares — an estimated $23.2K sold.

Millennium Management first reported a position in TRAW in Q4 2014 and held it in 13 quarters. The position peaked at $2.82M in Q1 2021. 19 funds tracked by Wall St. Rank hold TRAW as of Q2 2025.

  • Millennium Management reported no remaining Traws Pharma position as of Q2 2025 after selling out during the quarter.
  • Millennium Management sold 10,071 Traws Pharma shares in Q2 2025, an estimated $23.2K.
  • Millennium Management first reported a position in Traws Pharma in Q4 2014 and held it in 13 quarters.
  • Millennium Management's Traws Pharma position peaked at $2.82M in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2025.

Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.